ArticlePloS one2012

Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients.

Montserrat de Castellarnau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.